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Background: Bullous keratopathy (BK), a severe sight-threatening disorder can have a variety of etiologies such as
prophylactic laser iridotomy, intraocular surgery, trauma, and other ocular disorders. However, there are cases of
unknown origins, among which a unique clinical entity namely pseudoexfoliation syndrome (PEX) is having
increased importance.
Case presentation: In this case note, we report the clinical features and in vivo confocal microscopic and
pathological findings of two BK cases of unknown cause.
Conclusions: Our findings suggest that the BK was caused by the corneal endotheliopathy of PEX, a common
disease that could affect up to 30% of people over 60 years old and is more prevalent than we have believed.
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Bullous keratopathy (BK), a sight-threatening disorder
caused by endothelial cell dysfunction, is one of the leading
causes for corneal transplantation in many countries. A re-
cent national survey in Japan showed the most common
cause of BK was cataract surgery, followed by prophylactic
laser iridotomy, glaucoma surgery, trauma, and other ocu-
lar diseases [1]. However, there are cases of which the
etiology is unknown. In this note, we report the clinical
features and in vivo confocal microscopic (IVCM) and
pathological findings of two BK patients diagnosed with an
unknown cause. Our findings suggest that the BK was
probably caused by the corneal endotheliopathy of pseu-
doexfoliation syndrome (PEX), a common disease that
could affect up to 30% of people over 60 years old [2].* Correspondence: xzheng@m.ehime-u.ac.jp
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Case 1
An 82-year-old man complained of blurred vision in his
right eye of one year duration visited our hospital. He had
no history of intraocular surgery and trauma, and his
medical records showed that he was not taking any medica-
tion, such as major tranquilizers, that could cause corneal
endotheliopathy.
On our examination, his best-corrected visual acuity
(BCVA) was 0.04 (Snellen: 20/500) OD and 0.8 (20/25) OS.
The intraocular pressure was 12 mmHg OD and 10 mmHg
OS. The right cornea was diffusely edematous and the
details of the iris and lens were barely visible (Figure 1A).
No inflammatory signs were found in the anterior chamber
and vitreous, and the retinal reflex was normal. IVCM
showed characteristic changes of the endothelial cells with
increased polymorphism and pleomegatism. Abundant
PEX materials were found deposited on the corneal
endothelial cells (Figure 1B). It was noteworthy that PEX
materials were also found in the subbasal layer and stroma
of the cornea (Figure 1C).Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Findings in a patient with unknown bullous keratopathy (Case 1). A. Slit-lamp photograph showing diffused corneal edema. B and
C. In vivo confocal microscopy of the endothelial layer showing abundant irregular hyperreflective materials most likely PEX materials in the
endothelium (B, arrows; Bar = 50 μm) and stroma of the cornea (C, arrows; Bar = 50 μm). D and E. Hematoxylin-eosin staining of light microscopy
showing apparent loss of endothelium and formation of fibrillar layer (D, double arrows) and the fibroblast-like change of an endothelium (E). St:
stroma, De: Descemet membrane, Bar = 10 μm. F and G. Scanning electronic microscopy showing PEX fibers (open arrows) adjacent to destroyed
endothelium (F; En: endothelium) and transmission electron microscopic identification of PEX fibers (arrows in enlarge window) in the thickened
Descemet membrane (G; St: stroma, De: Descemet membrane, original magnification: x5000). H. Anti-LOXL1 immunohistochemical staining
showing positive staining within the stroma of the cornea (arrows). St: stroma, De: Descemet membrane, Bar = 10 μm. Window image shows
negative control staining without LOXL1 antibody.
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penetrating keratoplasty in combination with cataract
extraction and intraocular lens insertion. He recovered
well with a clear corneal graft and his final BCVA was
0.8 (Snellen 20/25) at his final visit to our department at
3 years after surgery.
The removed cornea was processed for pathology.
Histological study showed that there was a marked loss ofendothelial cells, formation of fibrillar layer (Figure 1D),
and fibroblast-like changes of the remaining cells
(Figure 1E). Electron microscopy identified abundant PEX
materials deposited on the corneal endothelium and within
the thickened Descemet layer (Figures 1F and 1G). Immu-
nohistochemical studies using anti-LOXL1 antibody con-
firmed positive staining correlating with the PEX materials
deposited in the stroma (Figure 1H).
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A 76-year-old woman had decreased vision in her left
eye and was diagnosed with BK of unknown cause. She
also had no history of intraocular surgery, laser therapy,
and trauma before the onset of BK. On her visit to our
hospital, her BCVA was 0.1 (Snellen 20/200) in the left
eye, and the intraocular pressure was 13 mmHg. Dif-
fused corneal edema was present and there were no
signs of inflammation in this eye (Figure 2A). Both of
her eyes had PEX materials in the pupillary area and
right lens capsule (Figure 2B). IVCM showed typical
PEX materials deposits on the endothelial layers and the
anterior stroma of the edematous cornea (Figure 2C).
DSAEK was performed and the removed endothelial
layer was examined by electron microscopy. Extensive PEX
materials were found on the destroyed endothelial cell layer
(Figure 2D). She recovered uneventful after the surgery and
her BCVA was 0.9 (Snellen 20/22) at her latest visit 9 month
after the surgery.
Discussion
PEX is a common age-related disorder of the extracellu-
lar matrix and is frequently associated with severe
chronic secondary open angle glaucoma and cataracts
[2]. Recently, a mutation of the LOXL1 gene was shown
to be responsible for PEX, indicating a systemic abnor-
mality in this clinical entity [3]. Evidence has been accu-
mulating documenting the morphological alterations in
almost all cell layers of the cornea in PEX [4]. The PEXFigure 2 Findings in another patient with unknown bullous keratopa
and giant epithelial bullae. B. Slit-lamp photograph showing PEX materials
materials on the endothelial cells (arrows; Bar = 50 μm). D. Scanning electro
a destroyed endothelium. En: endothelium, original magnification: x5000.can lead to corneal endothelial cell decompensation,
which can result in severe BK, a vision-threatening
disorder [2,5].
In our two cases, PEX was the only recognizable factor
that could be responsible for the development of BK. To
date, there has been no report on simultaneous descrip-
tion of the IVCM and electron microscopic findings in
the PEX related BK in the literature. The IVCM findings
in this report were in agreement with our earlier obser-
vations that the endothelial cell density was significantly
decreased and PEX materials were precipitated on the
endothelial cells. More interestingly, the PEX materials
were also found in the stroma as detected by our immu-
nohistochemical study.
The origin of the PEX materials is still controversial
although fibroblastic changes of endothelial cells have
been suggested to be responsible for PEX material
formation [2]. Our findings also showed that IVCM is
a useful noninvasive and rapid method for diagnosing
PEX endotheliopathy. Early diagnosis of these patients
before intraocular surgery or laser iridotomy is critical
for better preservation of the endothelial function.
Our recent survey showed that the PEX endotheliopa-
thy comprises up to 50% of the unknown BK cases in
Japan (Japanese Ministry of Health PEX Endothelio-
pathy Study Group). Alert should be raised to this
unique clinical entity that relates to aging process, bi-
laterally involved and is probably more prevalent than
we have believed.thy (Case 2). A. Slit-lamp photograph showing diffused corneal edema
on the pupillary iris. C. In vivo confocal microscopy showing PEX
nic microscopy showing fabric PEX materials (open arrow) adjacent to
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Our in vivo confocal microscopic and histopathological
studies showed the endothelial dysfunction of the two
cases are probably associated with pseudoexfoliation syn-
drome. PEX related corneal endotheliopathy should be
taken into consideration as one possible etiology for bul-
lous keratopathy of unknown origin. In vivo confocal mi-
croscopy is a useful tool for assistance of the diagnosis.
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